Redefining nanomanufacturing.

Introducing

HMC - Hybrid Multiphasic Carriers.

A green platform that adaptively nano-encapsulates sensitive actives - ambient-temperature, solvent-free, single-vessel, and built to scale.

GentleEco-friendlyCost-effective

Technology

The manufacturing layer, rethought.

One carrier holds water-loving, oil-loving and amphiphilic actives together - each protected from oxidation.

Made without the heat, solvents or harsh high-energy steps of conventional routes - a gentle, low-energy path that keeps sensitive cargo intact.

Outcomes

  1. Ambient temperature - no heat step
  2. Solvent-free - no organic solvents
  3. Single-vessel - gentle, low-energy handling
  4. Ambient-stable - no cold chain
  5. Fully redispersible after storage

Validation Accelerated stability testing to international (ICH) guidelines.

Intellectual property Patent application AU 2024219996— view on the public register (opens in a new tab) Filed 2024 · Two further filings in preparation.

Applications & sectors

Where it lands, and where it's headed.

One finished product proves it works. The rest are open fields - each with its own reason the same carrier could matter, and its own kind of partner.

Made gently - without the heat, solvents or harsh, high-energy steps of conventional routes.

Fig. 01Product shot
The finished omega-3, as it reaches the shelf.

Validation Accelerated stability testing to ICH Q1A(R2), under ISO/IEC 17025-accredited methods.

Services

License the platform. Partner to scale.

Engagement routes

  • Platform licensing

    License HMC for your product category.

  • Technology transfer

    We move the capability into your operation.

  • Co-development

    Build a formulation together, from active to finished carrier.

  • GMP manufacturing

    We can also manufacture your formulations at our trusted, GMP-approved and licensed sites.

Figure Manufacturing at GMP-approved, licensed sites.

Who it’s for

  • Supplement brands
  • Pharmaceutical & biopharma formulation teams
  • CDMOs
  • API suppliers
  • Consumer-health companies
  • Strategic investors

Trusted by

  • Inoclon
  • Caruso's Natural Health
  • Nahrin
  • Meris Pharmaceutical
  • Gumellow
  • Pediabest
  • EterniVit
  • Kaygenic
  • Green Nature
  • CinnaGen
  • Minga Pharmaceutical
  • DentiSmart
  • Momelle
R&D · Active projects

The open questions we're working through.

Beyond the proven omega-3, HMC opens onto a set of exploratory programmes - early, partner-led and evidence-first. These are directions we're actively investigating, not finished products or claims.

  • Active exploration

    Co-delivery systems

    One carrier holding water-loving, oil-loving and amphiphilic actives together - with built-in protection for oxidation-prone cargo.

    Theme: multi-phase actives held together in a single carrier.

  • Research / partner-stage

    Pharma-grade & injectable-route

    The same ambient, solvent-free, single-vessel handling brought to fragile APIs and injectable-route applications. Collaborative and evidence-led.

    Theme: partner-led, evidence-first feasibility for demanding payloads.

  • Exploring

    Beauty & skin actives

    Topical delivery of delicate actives, kept stable and effective - gentle on the active, kind to skin.

    Theme: keeping delicate topical actives stable through to the skin.

  • Early frontier

    Functional coatings

    The encapsulation principles applied beyond delivery, toward engineered coatings. A speculative frontier we're only beginning to probe.

    Theme: encapsulation principles applied to a surface, not a body.

Note These are research directions, not products — we’re open to formulation, brand and research partners to take them further.

Contact

Start a conversation.

Tell us how you'd like to work together. We route enquiries by type so the right person replies.

Enquiry type (required)

VesiNex Biosystems Ltdinfo@vesinex.com